Identifying adverse drug reaction signal pairs by a multi-agent intelligent system with fuzzy decision model

Abstract

Several thousands of drugs are currently available on the U.S. market. A complete understanding of the safe use of drugs is not possible at the time when drug is developed or marketed. At that time, the safety information is only obtained from a few thousand people in a typical pre-marketing clinical trial. Clinical trials are not capable of detecting rare… (More)

Topics

12 Figures and Tables

Slides referencing similar topics